Cannin Group
Posted by Cannin Group on Oct 1, 2018 4:00:00 PM

Louisiana Selects Nine Pharmacies to Sell Medical Cannabis through GB Sciences and LSU

 

On August 23, 2018, roughly three years after passage of the Alison Neustrom Act, the Louisiana Pharmacy Board issued permits to nine pharmacists to dispense medical marijuana in their regions, with a potential 10th license to be awarded at a later date.


GB Sciences, Inc. (OTCQB:GBLX), working with LSU AgCenter, has their first cannabis crop in production at a 36,000 sf (0.8 acres) grow facility in Baton Rouge. They are working with Louisiana pharmacists to serve patients starting in November.


Patients must have a prescription from a physician for a qualifying medical condition. Pharmacists will dispense pills, oils, and topical solutions. None of the medical cannabis may be smoked.


GB Sciences, Inc. (OTCQB: GBLX) is a diverse cannabis company, developing standardized cultivation and production methods, as well as biopharmaceutical R&D. Its goal is creating safe, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions.


The LSU AgCenter provides Louisiana with research-based information to improve lives. It includes the Louisiana Agricultural Experiment Station, which conducts research, and the Louisiana Cooperative Extension Service, which extends the knowledge to the state.

 

Source GB Sciences press release

Tags: Technology/Innovations, Medical

Investor Access